Excerpts

However, by three months, a borderline significant reduction in AL was observed in the LLRL group compared to the control group (estimate: -0.154; 95% CI: -0.282 to 0.026; p = 0.062) (Figure 4C ).

No significant associations were found with other serological markers, except for a near-significant trend with anti-Ro (anti-Ro/SSA antibodies) (P = 0.062).

By contrast, the trend toward significance with anti-Ro in our study (p = 0.062) suggests that this marker remains a strong predictor of suggestive LSGB findings.

A Fisher’s exact test demonstrated a strong trend toward statistical significance for this disparity (p = 0.0621).

This was trending towards significance (p=0.063).

A near-significant trend was observed between younger age (<40 years) and a higher stricture incidence (p = 0.063).

Although cardiovascular death showed a trend (22.8 vs. >24 months, p=0.063), all-cause mortality was significantly higher in CMD patients (21.6 vs. >24 months, p=0.041).

Reduced hematocrit during a worsening of symptoms was associated with prolonged hospital stay with borderline significance (p = 0.063; Table 2 ).

n=11; 64.7%), with a trend toward significance (p=0.063), whereas previous pancreatitis was comparably less common in both groups (n=3; 10.3% vs. n=3; 17.6%; p=0.48).

While HbA1C approached significance in the PDR group (B = 0.931, OR = 2.530, p = 0.063), indicating a trend where higher HbA1C values were associated with higher PDR risk, it did not significantly predict NPDR.

A chi-square test of independence revealed a marginally non-significant association between EF groups and the presence of Atrial Fibrillation (AF), with a Pearson Chi-Square value of 5.536 (df = 2, p = 0.063) and a Likelihood Ratio of 5.757 (p = 0.056).

When comparing between the two groups, the improvement in scores was higher in the hands-on training group than the observational training group, and this was marginally significant (p=0.063).

The mean oxycodone dose was significantly higher in the P group (2.83 ± 2.95 mg) compared to the R group (1.10 ± 1.81 mg) (t = -2.367, P = 0.023), whereas oxycodone use showed a trend toward significance (0.29 ± 0.46 vs. 0.57 ± 0.51, t = -1.912, P = 0.063).

Wound gape was more commonly reported in Group B (7, 8.2%) than in Group A (1, 1.2%), showing a trend toward significance (p = 0.0639).

While neither factor reached statistical significance in the multiple regression model, age before the switch showed a trend toward significance as a potential predictor of fatty liver index reduction (p = 0.064).

Within this model, symptomatic vasospasm and DCI remained strongly significant predictors (p<0.001 for both), while GCS became borderline non-significant (p=0.064).

For DBP, gender remained a significant predictor, F(1, 30) = 12.88, p = 0.001, explaining around 30% of the variance, while BMI showed a nonsignificant trend, F(1, 30) = 3.69, p = 0.064, accounting for about 11%.

LH (r=0.308) showed a moderate positive correlation, with a p-value approaching significance (P=0.064), while serum insulin (r=0.331) exhibited a very weak positive correlation, also nearing statistical significance (P=0.084).

Pairwise comparisons showed a marginally significant difference in total fluid administration across all groups (p=0.064), and a statistically significant difference between the CFT and GDFT/ED groups (p=0.003).

29.2% in SMT), although the difference approached but did not reach significance (p = 0.064).

CVICU admission NephroCheck values showed a trend toward being higher in the AKI group (0.49 ± 0.59 vs 0.09 ± 0.04, p = 0.064), though not reaching statistical significance.

There was a strong trend in functional independent outcome (mRS ≤ 2) for patients with ATA visualization (63.8% vs. 45.5%, p = 0.064).

The results indicate that the treatment group significantly influences PI (p = 0.000081), GI (p = 0.000002), and bone loss percentages (p = 0.002394), while age is not a significant covariate for both PI and GI and marginally non-significant (p = 0.064246) for bone loss percentage (Table 3 ).

The other rating tool showed a trend suggestive of superior performance with the use of the SPA CEC which did not reach significance [52.1% with a CEC vs. 44.5% without a CEC (p = 0.065)].

Proximity to the hospital was significant (B = -0.147, p = 0.038, Exp(B) = 0.864), but financial cost approached significance (B = -0.203, p = 0.065).